Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost–Utility Analysis

被引：0
|
作者：
Peng Men
Shuli Qu
Zhenqiang Song
Yanjun Liu
Chaoyun Li
Suodi Zhai
机构：
[1] Peking University Third Hospital,Department of Pharmacy
[2] Peking University Health Science Center,Institute for Drug Evaluation
[3] IQVIA,Real
[4] Tianjin Medical University Chu Hisen-I Memorial Hospital,World Insights Division
[5] Sanofi,Health Economics and Outcome Research
来源：
Diabetes Therapy | 2020年 / 11卷
关键词：
Chinese; Economics; GLP-1 analogue; Network meta-analysis; Type 2 diabetes;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1745 / 1755
页数：10
相关论文
共 50 条
  • [1] Lixisenatide for Type 2 Diabetes Mellitus Patients Inadequately Controlled on Oral Antidiabetic Drugs: A Mixed-Treatment Comparison Meta-analysis and Cost-Utility Analysis
    Men, Peng
    Qu, Shuli
    Song, Zhenqiang
    Liu, Yanjun
    Li, Chaoyun
    Zhai, Suodi
    DIABETES THERAPY, 2020, 11 (08) : 1745 - 1755
  • [2] Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
    Satoshi Ida
    Ryutaro Kaneko
    Kazuya Murata
    Cardiovascular Diabetology, 17
  • [3] Effects of oral antidiabetic drugs on left ventricular mass in patients with type 2 diabetes mellitus: a network meta-analysis
    Ida, Satoshi
    Kaneko, Ryutaro
    Murata, Kazuya
    CARDIOVASCULAR DIABETOLOGY, 2018, 17
  • [4] Comparison of lixisenatide in combination with basal insulin vs other insulin regimens for the treatment of patients with type 2 diabetes inadequately controlled by basal insulin: Systematic review, network meta-analysis and cost-effectiveness analysis
    Men, Peng
    Qu, Shuli
    Luo, Wenting
    Li, Chaoyun
    Zhai, Suodi
    DIABETES OBESITY & METABOLISM, 2020, 22 (01) : 107 - 115
  • [5] Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis
    Dan Qian
    Tiantian Zhang
    Peiying Zheng
    Zhuoru Liang
    Sen Wang
    Jingmei Xie
    Lina Zhao
    Ying Zhang
    Bing Situ
    Diabetes Therapy, 2018, 9 : 1945 - 1958
  • [6] Comparison of Oral Antidiabetic Drugs as Add-On Treatments in Patients with Type 2 Diabetes Uncontrolled on Metformin: A Network Meta-Analysis
    Qian, Dan
    Zhang, Tiantian
    Zheng, Peiying
    Liang, Zhuoru
    Wang, Sen
    Xie, Jingmei
    Zhao, Lina
    Zhang, Ying
    Situ, Bing
    DIABETES THERAPY, 2018, 9 (05) : 1945 - 1958
  • [7] A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy
    Michelle Orme
    Peter Fenici
    Isabelle Duprat Lomon
    Gail Wygant
    Rebecca Townsend
    Marina Roudaut
    Diabetology & Metabolic Syndrome, 6
  • [8] A systematic review and mixed-treatment comparison of dapagliflozin with existing anti-diabetes treatments for those with type 2 diabetes mellitus inadequately controlled by sulfonylurea monotherapy
    Orme, Michelle
    Fenici, Peter
    Lomon, Isabelle Duprat
    Wygant, Gail
    Townsend, Rebecca
    Roudaut, Marina
    DIABETOLOGY & METABOLIC SYNDROME, 2014, 6
  • [9] Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis
    Rimei Nishimura
    Mayumi Taniguchi
    Tomomi Takeshima
    Kosuke Iwasaki
    Advances in Therapy, 2022, 39 : 632 - 654
  • [10] Efficacy and Safety of Metformin Versus the Other Oral Antidiabetic Drugs in Japanese Type 2 Diabetes Patients: A Network Meta-analysis
    Nishimura, Rimei
    Taniguchi, Mayumi
    Takeshima, Tomomi
    Iwasaki, Kosuke
    ADVANCES IN THERAPY, 2022, 39 (01) : 632 - 654
12345